Mayne Pharma Group Ltd (myx) Logo

Mayne Pharma Group Ltd (MYX)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

MYX ASX Chart

Snapshot

Mayne Pharma (MYX) is a pharmaceutical company focused on commercialising branded women's health and dermatology pharmaceuticals. Mayne Pharma has a 40 year track record of innovation and success in developing new oral drug delivery systems and these technologies have been commercialised in products that continue to be marketed around the world. Mayne Pharma has formulation of complex oral and topical dose forms including release products and poorly soluble compounds.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) +83.13%
vs ASX 200 (1yr) +76.49%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 424 of 2,383
Sector Rank 24 of 223

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies MVF / IDX / ACL
EPS -$3.86
DPS $0.00
Book Value Per Share $0.201

Broker Consensus

Breakdown 0 Buy · 5 Hold · 4 Sell
Recommendation Sell
Last Updated 01/02/24

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Salisbury South SA 5106
Website www.maynepharma.com
Registry Computershare
Auditor Ernst & Young
Date Listed 29 Jun 2007

Upcoming Calendar (Forecasted)

Date Event
29/08/2024 Report (Prelim)
12/09/2024 Report (Prelim)
23/10/2024 Report (Annual)
24/02/2025 Report (Interim)

Former Company Names

  • Halcygen Pharmaceuticals Limited (HGN), 18/11/2010

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
03/03/2011 $0.01 100% $0.0143 Interim 25/03/2011
25/10/2010 $0.02 100% $0.0286 Final 18/11/2010

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.00
Gross DPS(TTM) $0.00
Dividend yield
Gross yield
Payout Ratio --
DRP No
DRP Features --

Directors & Management

Directors

Management

Director Transactions

MYX directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
08/12/23 Shawn O'Brien Issued 290,554 $5.85 $1,699,740 Issue of securities
01/12/23 Frank Condella Buy +7,154 $5.43 $38,811 On-market trade
25/10/23 Kathryn MacFarlane Buy +18,000 $3.84 $69,120 On-market trade
24/10/23 Shawn O'Brien Buy +37,041 $3.80 $140,917 On-market trade
23/10/23 Ann Custin Buy +6,037 $3.35 $20,207 On-market trade
20/10/23 Ann Custin Buy +6,250 $3.35 $20,920 On-market trade
17/04/23 Ann Custin Buy +9,075 $4.06 $36,844 On-market trade
13/04/23 Patrick Blake Buy +3,097 $4.07 $12,591 On-market trade
12/04/23 Patrick Blake Buy +6,000 $4.12 $24,749 On-market trade
30/03/23 Carolyn Myers Buy +20,000 $3.73 $74,527 On-market trade
29/03/23 Kathryn MacFarlane Buy +20,000 $3.81 $76,156 On-market trade
27/03/23 Frank Condella Buy +3,210 $3.52 $11,291 On-market trade
24/03/23 Frank Condella Buy +17,788 $3.52 $62,691 On-market trade
16/03/23 Shawn O'Brien Issued 364,103 $3.57 $1,299,847 Issue of securities
30/09/22 Scott Richards Transfer 5,585,369 $0.275 $1,535,976 Off-market transfer
30/09/22 Scott Richards Transfer 5,585,369 $0.275 $1,535,976 Off-market transfer
01/08/22 Scott Richards Cancelled 6,608,851 $0.350 $2,313,097 Cancellation of securities
03/12/21 Scott Richards Issued 6,060,606 $0.270 $1,636,363 Issue of securities
01/09/21 Frank Condella Buy +412,121 $0.332 $136,679 On-market trade
04/12/20 Scott Richards Issued 1,125,492 $0.360 $405,177 Issue of securities
04/12/20 Scott Richards Issued 8,643,782 $0.355 $3,072,000 Issue of securities
01/09/20 Frank Condella Buy +110,696 $0.337 $37,287 On-market trade
31/08/20 Scott Richards Cancelled 2,553,496 $0.335 $855,421 Cancellation of securities
11/03/20 Bruce Mathieson Buy +3,112,726 $0.316 $982,336 On-market trade
11/03/20 Bruce Mathieson Buy +3,112,726 $0.316 $982,335 On-market trade
03/03/20 Bruce Mathieson Buy +3,687,274 $0.317 $1,170,433 On-market trade
03/03/20 Bruce Mathieson Buy +3,687,274 $0.317 $1,170,433 On-market trade
09/12/19 Scott Richards Issued 5,145,686 $0.470 $2,415,900 Issue of securities
09/12/19 Scott Richards Issued 2,555,805 $0.430 $1,098,996 Issue of securities
18/10/19 Frank Condella Buy +50,897 $0.593 $30,194 On-market trade
16/10/19 Patrick Blake Buy +260,000 $0.592 $154,045 On-market trade
24/12/18 Frank Condella Buy +181,835 $0.766 $139,334 On-market trade
07/12/18 Scott Richards Issued 6,229,373 $0.970 $6,040,000 Issue of securities
20/12/17 Scott Richards Sell +4,000,000 $0.681 ($2,725,600) On-market trade
07/12/17 Scott Richards Issued 6,608,851 $0.617 $4,077,000 Issue of securities
07/12/17 Scott Richards Sell +7,283,195 $0.625 ($4,551,997) As advised by the company
28/08/17 Bruce Mathieson Buy +8,000,000 $0.686 $5,485,146 On-market trade
10/05/17 Scott Richards Buy +3,500,000 $0.149 $522,200 Exercise of options
16/03/17 Bruce Mathieson Buy +908,084 $1.29 $1,167,929 On-market trade
21/12/16 Scott Richards Buy +4,000,000 $0.149 $596,800 Exercise of options
21/12/16 Scott Richards Exercise 4,000,000 $0.149 $596,800 Exercise of options
20/12/16 Ian Scholes Buy +100,000 $1.26 $126,250 On-market trade
19/12/16 Ron Best Buy +18,711 $1.27 $23,741 On-market trade
16/12/16 Bruce Robinson Buy +43,376 $1.30 $56,280 On-market trade
08/12/16 Bruce Mathieson Buy +200,000 $1.45 $290,333 On-market trade
02/12/16 Bruce Robinson Buy +184,000 $1.62 $298,080 On-market trade
21/09/16 William Hodges Sell +1,330,000 $2.00 ($2,660,270) On-market trade
08/09/16 William Hodges Sell +337,000 $2.00 ($675,150) On-market trade
16/08/16 Ron Best Transfer 39,000 $1.28 $49,920 Off-market transfer
16/08/16 Ron Best Issued 52,336 $1.28 $66,990 Rights issue
22/07/16 Ron Best Issued 24,543 $1.28 $31,415 Rights issue
22/07/16 Scott Richards Issued 5,778,197 $1.28 $7,396,092 Rights issue
07/07/16 William Hodges Issued 1,566,887 $1.28 $2,005,615 Rights issue
07/07/16 Ron Best Transfer 2,450,000 $0.988 $2,420,703 Off-market transfer
07/07/16 Ron Best Issued 1,402,289 $1.30 $1,817,970 Rights issue
07/07/16 Bruce Mathieson Issued 33,126,419 $1.28 $42,401,816 Rights issue
07/07/16 Roger Corbett Issued 3,774,227 $1.28 $4,831,011 Rights issue
07/07/16 Bruce Robinson Issued 149,548 $1.28 $191,421 Rights issue
07/07/16 Ian Scholes Issued 755,462 $1.28 $966,991 Rights issue
04/12/15 Scott Richards Issued 2,553,496 $1.23 $3,140,800 Issue of securities
04/09/15 Bruce Mathieson Buy +680,000 $1.10 $745,135 On-market trade
31/08/15 Ron Best Buy +68,000 $1.08 $73,300 On-market trade
11/03/15 Ron Best Sell +68,326 $0.946 ($64,661) On-market trade
11/03/15 Ron Best Issued 345,082 $0.610 $210,500 Rights issue
11/03/15 Scott Richards Issued 1,090,367 $0.610 $665,124 Rights issue
11/03/15 Ian Scholes Issued 292,848 $0.610 $178,637 Rights issue
11/03/15 Ian Scholes Transfer 350,000 $0.935 $327,250 Off-market transfer
11/03/15 Ian Scholes Transfer 350,000 $0.935 $327,250 Off-market transfer
20/02/15 Bruce Mathieson Issued 12,688,332 $0.610 $7,739,883 Rights issue
20/02/15 William Hodges Issued 1,536,929 $0.610 $937,527 Rights issue
20/02/15 Bruce Robinson Issued 57,971 $0.610 $35,362 Rights issue
20/02/15 Roger Corbett Issued 1,463,043 $0.610 $892,456 Rights issue
22/12/14 Scott Richards Issued 1,388,371 $0.682 $946,175 Issue of securities
16/12/14 Bruce Robinson Buy +100,000 $0.598 $59,800 On-market trade
05/12/14 Scott Richards Issued 2,435,158 $0.682 $1,659,560 Issue of securities
06/10/14 Bruce Robinson Buy +300 $0.750 $225 On-market trade
02/10/14 Bruce Robinson Buy +99,700 $0.750 $74,790 On-market trade

Director Interests

The current holdings of MYX directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Frank Condella 01/12/2023 65,929 N/A N/A N/A
Anne Lockwood 30/11/2023 0 N/A N/A N/A
Kathryn MacFarlane 25/10/2023 38,000 N/A N/A N/A
Shawn O'Brien 24/10/2023 37,041 N/A N/A N/A
Ann Custin 23/10/2023 21,362 N/A N/A N/A
Patrick Blake 14/09/2023 N/A 22,097 N/A N/A
Bruce Robinson 14/09/2023 31,745 N/A N/A N/A
David Petrie 01/09/2022 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Sep 18, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Citicorp Nominees Pty Limited 10,761,314 12.90%
HSBC Custody Nominees (Australia) Limited 7,245,424 8.70%
J P Morgan Nominees Australia Pty Limited 6,792,556 8.10%
Mr Bruce Mathieson And Related Entities 5,292,066 6.30%
Estetra Srl <No 1 Account> 4,221,815 5.10%
HSBC Custody Nominees (Australia) Limited <Gsco Customers A/C> 3,369,950 4.00%
Solium Nominees (Australia) Pty Ltd <Bare Allocated A/C> 2,359,715 2.80%
National Nominees Limited 2,052,695 2.50%
Bnp Paribas Noms Pty Ltd <Drp> 1,954,119 2.30%
Gft 2 Co Pty Limited <Gft 2 A/C> 1,295,569 1.60%
Ivl Group Pty Ltd 800,000 1.00%
Vivnat (Curtin) Pty Ltd 750,000 0.90%
R & R Corbett Pty Ltd <R C Corbett Family A/C> 522,028 0.60%
Y S Chains Pty Ltd 500,000 0.60%
Retzos Executive Pty Ltd <Retzos Executive S/Fund A/C> 465,000 0.60%
Mr Kon Tzimokas 400,000 0.50%
Wal Assets Pty Ltd <The La Wilson Property A/C> 354,500 0.40%
Birbal Investments Pty Ltd 300,000 0.40%
Mr Yunsong Zhang 300,000 0.40%
Belgravia Strategic Equities Pty Ltd 295,250 0.40%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 8,424 2,673 506 534 59 12,196

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Viburnum Funds Pty Ltd and subsidiaries and associates 18/09/2023 6,428,268 7.70
B L Mathieson 18/09/2023 5,292,066 6.30
Rubric Capital Management LP 18/09/2023 4,356,426 5.20
The Goldman Sachs Group, Inc. 12/12/2023 5,220,300 6.14

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
23-02-24 UBS Group AG and its related bodies corporate 4,305,356 -- 5.06
12-12-23 The Goldman Sachs Group, Inc. 5,220,300 -- 6.14
24-07-23 Viburnum Funds Pty Ltd and subsidiaries and associates 1,123,793 6.16 7.48
19-06-23 The Goldman Sachs Group, Inc. 6,559,698 -- 7.71
16-06-23 Rubric Capital Management LP 4,356,426 -- 5.10
30-05-23 Viburnum Funds Pty Ltd and subsidiaries and associates 874,278 5.13 6.16
23-05-23 Lazard Asset Management Pacific Co 4,265,597 -- 5.01
04-05-23 Viburnum Funds Pty Ltd and subsidiaries and associates 4,362,521 -- 5.13
14-03-23 Lazard Asset Management Pacific Co 879,671 5.29 6.32

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
26-02-24 UBS Group AG and its related bodies corporate 4,305,356 5.06 --
31-10-23 The Goldman Sachs Group, Inc. 6,559,698 7.71 --
21-06-23 Mithra pharmaceuticals SA and its associates 168,872,626 9.57 --
13-06-23 Lazard Asset Management Pacific Co 4,265,597 5.01 --
19-05-23 Lazard Asset Management Pacific Co 5,419,443 6.32 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $4.40 30 June
2022 $0.250 30 June
2021 $0.320 30 June
2020 $0.385 30 June
2019 $0.510 28 June
2018 $0.870 29 June
2017 $1.09 28 June
2016 $1.91 28 June
2015 $0.985 30 June
2014 $0.850 30 June
MYX Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.